Galderma Reports Strong Start to the Year, Delivering First Quarter 2026 Net Sales of 1.473 Billion USD, Growing 25.5% at Constant Currency

AI Briefing

• – Galderma reports strong Q1 2026 net sales of $1.473 billion, up 25.5% at constant currency.
• – The company's sales growth is driven by volume and positive price and mix effects.
• – Galderma's growth-driven integrated dermatology strategy is yielding results.